MintNeuro
About MintNeuro
MintNeuro develops scalable semiconductor technology for next-generation neural implants that enhance the treatment of neurological conditions through compact, low-power solutions. The company aims to improve patient outcomes by enabling minimally invasive procedures that offer high performance and accessibility in medical interventions.
```xml <problem> Current neural implants for treating neurological conditions often require invasive surgical procedures due to their size and complexity. These implants also have limited capabilities in sensing, processing, and modulating neural activity, hindering effective treatment and monitoring of neurological disorders. </problem> <solution> MintNeuro is developing next-generation neural implants utilizing scalable semiconductor technology to address the limitations of existing solutions. Their compact, low-power bioelectronic implants enable minimally invasive procedures, reducing patient risk and improving accessibility. By focusing on advanced integrated circuits, MintNeuro's technology facilitates high-performance sensing, processing, and modulation of neural activity. The company's modular chiplet approach allows for customized solutions that can be efficiently combined to address a wide range of neurological conditions, paving the way for more effective and less invasive therapeutic interventions. </solution> <features> - Ultra-low power integrated circuits engineered for high performance and long-term reliability - Wireless communication capabilities for seamless data transfer and remote monitoring - Miniaturized implantable devices designed for minimally invasive surgical procedures - Modular design using specialized "chiplets" for sensing, stimulation, and processing - Customizable solutions tailored to specific neurological conditions and patient needs - Focus on both sensing applications (e.g., epilepsy neuromonitoring, brain-computer interfaces) and neuromodulation - Development of a "neural chipset" with function-specific chips designed to work together across multiple applications </features> <target_audience> MintNeuro's primary target audience includes medical device companies, clinical researchers, and healthcare providers focused on developing and implementing advanced therapies for neurological conditions such as epilepsy, Parkinson's disease, and urinary incontinence. </target_audience> ```
What does MintNeuro do?
MintNeuro develops scalable semiconductor technology for next-generation neural implants that enhance the treatment of neurological conditions through compact, low-power solutions. The company aims to improve patient outcomes by enabling minimally invasive procedures that offer high performance and accessibility in medical interventions.
Where is MintNeuro located?
MintNeuro is based in London, United Kingdom.
When was MintNeuro founded?
MintNeuro was founded in 2022.
How much funding has MintNeuro raised?
MintNeuro has raised 1273670.
Who founded MintNeuro?
MintNeuro was founded by Dorian Haci and Timothy Constandinou.
- Dorian Haci - CEO
- Timothy Constandinou - Co-founder
- Location
- London, United Kingdom
- Founded
- 2022
- Funding
- 1273670
- Employees
- 16 employees
- Major Investors
- Imperial College London, Plug and Play, Empirical Ventures, Excellis, the Imperial College Innovation Fund